Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stranden

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Vascular Medicine (London, England)|December 1, 2007
Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) studyM Nylaende, A J Kroese, B Morken, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 5, 2005
Gadolinium-enhanced magnetic resonance angiography, colour duplex and digital subtraction angiography of the lower limb arteries from the aorta to the tibio-peroneal trunk in patients with intermittent claudicationE Gjønnaess, B Morken, G Sandbaek, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|May 3, 2008
Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot studyT Wester, J J Jørgensen, E Stranden, et al.
Journal of Cardiovascular Pharmacology|June 1, 1987
Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complicationsO Thulesius, J Lundvall, A Kroese, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 24, 2006
The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudicationM Nylaende, M Abdelnoor, E Stranden, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Vascular Medicine (London, England)|December 1, 2007
Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) studyM Nylaende, A J Kroese, B Morken, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 5, 2005
Gadolinium-enhanced magnetic resonance angiography, colour duplex and digital subtraction angiography of the lower limb arteries from the aorta to the tibio-peroneal trunk in patients with intermittent claudicationE Gjønnaess, B Morken, G Sandbaek, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|May 3, 2008
Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot studyT Wester, J J Jørgensen, E Stranden, et al.
Journal of Cardiovascular Pharmacology|June 1, 1987
Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complicationsO Thulesius, J Lundvall, A Kroese, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 24, 2006
The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudicationM Nylaende, M Abdelnoor, E Stranden, et al.
Pageof 10